GPR137B

Across TCGA pan-cancer cohorts, GPR137B Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated GPR137B data layer compared with 23 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher GPR137B Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated GPR137B expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, LUAD, and UCEC are the cancer types where GPR137B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.121	0.697	<.001	36	view →
LUAD	OS	Median	All	0.274	0.813	<.001	27	view →
UCEC	DFS	Median	All	1.000	0.614	.011	16	view →
LUSC	OS	Median	All	0.362	0.727	.034	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

GPR137B–HNSC (DFS)

Open the HNSC breakdown →